Nfj Investment Group, LLC Amgen Inc Transaction History

Nfj Investment Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $645,386 - $728,073	-2,524 Reduced 33.67%	4,973 $1.43 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $4,810 - $5,972	-22 Reduced 0.29%	7,497 $2.01 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $12,213 - $14,442	-57 Reduced 0.75%	7,519 $1.67 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $15,579 - $18,988	-69 Reduced 0.9%	7,576 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $75,579 - $96,033	-330 Reduced 4.14%	7,645 $2.01 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $19.2 Million - $21.6 Million	-85,348 Reduced 91.45%	7,975 $1.8 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.81 Million - $2.01 Million	-7,839 Reduced 7.75%	93,323 $22.7 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $2.65 Million - $2.93 Million	-12,078 Reduced 10.67%	101,162 $24.5 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $15.8 Million - $18 Million	79,258 Added 233.24%	113,240 $25.5 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $99,271 - $110,134	-425 Reduced 1.24%	33,982 $8.28 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $7.64 Million - $8.9 Million	34,407 New	34,407 $8.56 Million

3,084

401M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Nfj Investment Group, LLC with notifications on news.